Search results for: Paul Barnsley
Filter search results
Critique of CHE Research Paper 81: Methods for the Estimation of the NICE Cost Effectiveness Threshold
12 January 2013
…cost-per-QALY greater than this threshold. The critique by OHE’s Barnsley et al accepts the premise that NICE’s cost-effectiveness threshold should be set equal to the budget decrease that would cause…
Paul Catchpole
11 December 2023
Paul has worked in the healthcare, local government and pharmaceutical sectors for over 30 years. He began his career in the NHS as a researcher and then held a number…
OHE at ISPOR Europe: Posters
13 November 2014
…Ispor do nice_decisions_affect_decisions_in_other_countries from Office of Health Economics Karla Hernandez-Villafuerte, Paul Barnsley, Martina Garau and Nancy Devlin Ispor opportunity costs_sks from Office of Health Economics Sarah Karlsberg Schaffer, Jon…
OHE at HTAi Oslo: A New Drug Development Paradigm, a Framework for Developing Formularies in MICs, and the Effect of NICE Decisions Abroad
15 June 2015
…Feasibility Study Karla Hernández-Villafuerte (OHE), Paul Barnsley (Deloitte, formally OHE), Martina Garau (OHE) and Nancy Devlin (OHE). This poster looks at whether NICE recommendations on the use of…
OHE at HTAi Oslo: A New Drug Development Paradigm, and the Effect of NICE Decisions Abroad
19 June 2015
…have on that process. Do NICE Decisions Affect Decisions in Other Countries? A Feasibility Study Karla Hernández-Villafuerte (OHE), Paul Barnsley (Deloitte, formally OHE), Martina Garau (OHE) and Nancy…
Mike Paulden – 2022 Prize Finalist
18 January 2023
Dr Mike Paulden, PhD, is an Associate Professor at the School of Public Health, University of Alberta, Canada. He is a health economist with expertise in the economic evaluation of…